BeStock  

Danaher DHR

US equityMarket cap rank #119Diagnostics & Research
$230.25 +$3.91 (+1.73%)
Market closed · Nov 6, 9:40 pm ET · Last extended-hours $230.25 0.00%
Open$222.96
Prev close$226.34
Day range$222.96 – $230.66
Volume4.06M
Market cap$161.99B
P/E (TTM)37.7
Dividend yield0.66%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$6.55B+8.3% YoY
Operating profit$1.25B+7.9% YoY
Net profit$1.24B+36.0% YoY
Diluted EPS$1.75+37.8% YoY
Free cash flow$1.63B+19.1% YoY
Operating cash flow$1.89B

Revenue, last 8 quarters

$6.5BDec '24$5.7BMar '25$5.9BJun '25$6.1BSep '25$6.8BDec '25$6.0BMar '26$6.3BJun '26$6.6BSep '26

Net profit, last 8 quarters

$1.1BDec '24$954.0MMar '25$555.0MJun '25$908.0MSep '25$1.2BDec '25$1.0BMar '26$870.0MJun '26$1.2BSep '26

Diluted EPS by quarter

1.49Dec '241.32Mar '250.77Jun '251.27Sep '251.68Dec '251.45Mar '261.23Jun '261.75Sep '26

Free cash flow by quarter

$1.5BDec '24$1.1BMar '25$1.1BJun '25$1.4BSep '25$1.7BDec '25$1.1BMar '26$1.3BJun '26$1.6BSep '26

Annual revenue

$22.3BFY20$24.8BFY21$26.6BFY22$23.9BFY23$23.9BFY24$24.6BFY25

Profitability & balance sheet

Gross margin58.6%
Operating margin20.4%
Net margin16.9%
Return on equity8.3%
Return on assets5.0%
Return on invested capital6.1%
Current ratio1.63
Liabilities / assets42.5%
Cash & investments$5.68B
Total debt$26.48B
Net cash (debt)-$20.80B
Free cash flow / sales22.4%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Diagnostics$2.88B 44.0%
  • Life sciences$1.87B 28.5%
  • Biotechnology$1.81B 27.6%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $6.55B $6.27B $5.95B $24.57B $6.84B
Total Operating Revenue $6.55B $6.27B $5.95B $24.57B $6.84B
Cost of Revenue $2.72B $2.65B $2.36B $10.05B $2.87B
Gross Profit $3.84B $3.61B $3.59B $14.52B $3.97B
Operating Expense $2.59B $2.48B $2.25B $9.83B $2.46B
Selling and Admin Expenses $2.16B $2.07B $1.86B $8.24B $2.03B
Research & Development $433.00M $412.00M $387.00M $1.60B $438.00M
Operating Profit $1.25B $1.13B $1.34B $4.69B $1.50B
Net Non-Operating Interest Income (Expense) -$104.00M -$46.00M -$36.00M -$235.00M -$42.00M
Non-Operating Interest Income $31.00M $61.00M $27.00M $30.00M $13.00M
Non-Operating Interest Expense $135.00M $107.00M $63.00M $265.00M $55.00M
Other Income (Expense) -$9.00M -$3.00M -$73.00M -$222.00M -$87.00M
Gain on Sale of Security -$13.00M -$7.00M -$77.00M -$248.00M -$99.00M
Special Income (Charges) $0.00 $0.00 $0.00 $20.00M $11.00M
-Gain on Sale Of Business $0.00 $0.00 $0.00 $9.00M $0.00
Other Non-Operating Income (Expenses) $4.00M $4.00M $4.00M $6.00M $1.00M
Pretax Profit $1.13B $1.08B $1.24B $4.23B $1.37B
Tax -$75.00M $208.00M $206.00M $633.00M $190.00M
Net Profit $1.24B $870.00M $1.03B $3.61B $1.20B
Profit from Continuing Operations $1.21B $870.00M $1.03B $3.60B $1.18B
Net Income from Discontinuous Operations $28.00M – – $14.00M $14.00M
Net Income to Parent Company $1.24B $870.00M $1.03B $3.61B $1.20B
Net Income to Common Stockholders $1.24B $870.00M $1.03B $3.61B $1.20B
Basic EPS $1.75 $1.23 $1.45 $5.07 $1.69
Diluted EPS $1.75 $1.23 $1.45 $5.05 $1.68
Dividend Per Share $0.40 $0.40 $0.40 $1.28 $0.32
-Gain on Sale of Property/Plant/Equipment – – – $11.00M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $93.28B $92.37B $83.54B $83.46B $83.46B
Total Current Assets $14.79B $13.38B $13.94B $12.76B $12.76B
Cash and Cash Equivalents & Short-Term Investments $5.68B $4.35B $5.70B $4.62B $4.62B
-Cash and Cash Equivalents $5.68B $4.35B $5.70B $4.62B $4.62B
Receivables $4.13B $3.97B $3.82B $3.91B $3.91B
-Accounts Receivable $4.13B $3.97B $3.82B $3.91B $3.91B
Inventory $3.13B $3.26B $2.61B $2.49B $2.49B
Other Current Assets $1.85B $1.81B $1.81B $1.74B $1.74B
Total Non-Current Assets $78.49B $78.99B $69.61B $70.71B $70.71B
Net PPE $5.77B $5.83B $5.47B $5.53B $5.53B
-Gross PPE $10.82B $10.74B $10.30B $10.30B $10.30B
-Accumulated Depreciation -$5.04B -$4.92B -$4.83B -$4.77B -$4.77B
Goodwill and Other Intangible Assets $68.37B $68.77B $59.93B $60.97B $60.97B
-Goodwill $47.32B $47.41B $42.77B $43.15B $43.15B
-Other Intangible Assets $21.05B $21.36B $17.17B $17.82B $17.82B
Other Non-Current Assets $4.35B $4.39B $4.21B $4.21B $4.21B
Total Liabilities $39.65B $39.78B $30.59B $30.92B $30.92B
Total Current Liabilities $9.05B $8.11B $7.46B $6.81B $6.81B
Payables $1.74B $1.82B $1.79B $2.45B $2.45B
-Accounts Payable $1.74B $1.82B $1.79B $1.84B $1.84B
Current Accrued Expenses $5.21B $4.87B $4.75B – –
Short-Term Debt and Capital Lease Obligation $2.09B $1.41B $923.00M $201.00M $201.00M
-Current Debt $2.09B $1.41B $923.00M $2.00M $2.00M
Total Non-Current Liabilities $30.60B $31.67B $23.13B $24.12B $24.12B
Long Term Debt and Capital Lease Obligation $24.39B $25.15B $17.56B $19.50B $19.50B
-Long Term Debt $24.39B $25.15B $17.56B $18.42B $18.42B
Other Non-Current Liabilities $6.21B $6.52B $5.57B $184.00M $184.00M
Total Equity $53.63B $52.59B $52.96B $52.54B $52.54B
Stockholders' Equity $53.62B $52.58B $52.95B $52.53B $52.53B
Capital Stock $9.00M $9.00M $9.00M $9.00M $9.00M
-Common Stock $9.00M $9.00M $9.00M $9.00M $9.00M
Additional Paid-In Capital $17.63B $17.46B $17.30B $17.19B $17.19B
Retained Earnings $49.18B $48.23B $47.64B $46.89B $46.89B
Less: Treasury Stock $12.33B $12.32B $11.41B $11.35B $11.35B
Gains/Losses Not Affecting Retained Earnings -$865.00M -$795.00M -$593.00M -$207.00M -$207.00M
Minority Interests $12.00M $11.00M $8.00M $7.00M $7.00M
-Total Tax Payable – – – $532.00M $532.00M
-Other Payable – – – $75.00M $75.00M
-Current Capital Lease Obligation – – – $199.00M $199.00M
Current Provisions – – – $187.00M $187.00M
Current Deferred Liabilities – – – $1.35B $1.35B
Other Current Liabilities – – – $1.37B $1.37B
Long Term Accounts Payable and Other Payables – – – $3.23B $3.23B
-Long Term Capital Lease Obligation – – – $1.08B $1.08B
Derivative Product Liabilities – – – $0.00 $0.00
Non-Current Liabilities – – – $7.00M $7.00M
Non-Current Deferred Liabilities – – – $231.00M $231.00M
Employee Benefits – – – $968.00M $968.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $1.89B $1.53B $1.32B $6.42B $2.12B
Net cash flow from continuing operations $1.89B $1.53B $1.32B $6.42B $2.12B
Net Income from Continuing Operations $1.21B $870.00M $1.03B $3.60B $1.18B
Gain/Loss from Continuing Operations $13.00M $7.00M $77.00M $228.00M $88.00M
Depreciation & Depletion & Amortization $721.00M $659.00M $627.00M $2.45B $623.00M
Other Non-Cash Items $84.00M – – – –
Change in Working Capital -$306.00M -$141.00M -$469.00M -$719.00M $146.00M
-Change in Receivables -$160.00M $71.00M $66.00M -$216.00M -$151.00M
-Change in Inventory -$51.00M -$46.00M -$132.00M -$58.00M $184.00M
-Change in Prepaid Assets -$44.00M $121.00M -$40.00M -$55.00M -$2.00M
-Change in Payables and Accrued Expense -$51.00M -$287.00M -$363.00M $50.00M $555.00M
Net cash flow from investing -$300.00M -$10.15B -$249.00M -$1.20B -$384.00M
Net Cash Flow from Continuing Investing Activities -$300.00M -$10.15B -$249.00M -$1.20B -$384.00M
Net PPE Purchase and Sale -$254.00M -$269.00M -$237.00M -$1.12B -$348.00M
Net Business Purchase and Sale -$38.00M -$9.84B $0.00 $9.00M $0.00
Net Investment Purchase and Sale -$19.00M -$47.00M -$20.00M -$115.00M -$48.00M
Net Other Investing Changes $11.00M $12.00M $8.00M $33.00M $12.00M
Financing Cash Flow -$262.00M $7.27B $46.00M -$2.96B $1.32B
Net Cash Flow from Continuing Financing Activities -$262.00M $7.27B $46.00M -$2.96B $1.32B
Net Issuance Payments Of Debt -$7.00M $8.49B $309.00M $1.05B $1.52B
Net Common Stock Issuance $0.00 -$894.00M $0.00 -$3.00B $85.00M
Cash Dividends Paid -$281.00M -$283.00M -$226.00M -$878.00M -$226.00M
Proceeds from Stock Option Exercised $35.00M $8.00M -$9.00M – –
Net Other Financing Charges -$9.00M -$43.00M -$28.00M -$125.00M -$17.00M
Ending Cash Balance $5.68B $4.35B $5.70B $4.62B $4.62B
Net Change in Cash $1.32B -$1.34B $1.12B $2.26B $3.06B
Beginning Cash Balance $4.35B $5.70B $4.62B $2.08B $1.53B
Effect of Exchange Rate Changes $10.00M -$13.00M -$33.00M $278.00M $32.00M
Free Cash Flow $1.63B $1.27B $1.09B $5.26B $1.75B
-Change In Other Working Capital – – – -$440.00M –
Cash Flow from Discontinued Operating Activities – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on DHR.

Sign in to join the discussion.

Scroll to Top